Valuation: Tellgen Corporation

Market Cap 1.89B 278M 243M 224M 210M 394M 26.18B 402M 2.7B 1.04B 12.94B 1.04B 1.02B 44.87B P/E 2024
66.3x
P/E 2025 836x
Enterprise Value 1.68B 247M 216M 199M 187M 350M 23.26B 357M 2.4B 927M 11.5B 926M 906M 39.87B EV / Sales 2024
4.21x
EV / Sales 2025 7.5x
Free-Float
66.09%
Yield 2024
1.06%
Yield 2025 0.54%
1 day-2.64%
1 week-6.05%
Current month-15.34%
1 month-16.54%
3 months-29.37%
6 months-37.08%
Current year-35.78%
1 week 11.73
Extreme 11.73
13.03
1 month 11.73
Extreme 11.73
14.35
Current year 11.73
Extreme 11.73
22.87
1 year 11.73
Extreme 11.73
32.8
3 years 9.94
Extreme 9.94
32.8
5 years 9.94
Extreme 9.94
50.25
10 years 9.94
Extreme 9.94
50.25
Manager TitleAgeSince
Chief Executive Officer 56 06/11/2003
Director of Finance/CFO 50 09/06/2023
Chief Tech/Sci/R&D Officer 45 09/12/2020
Director TitleAgeSince
Chairman 56 06/11/2003
Director/Board Member 63 14/08/2019
Director/Board Member 44 09/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.64%-6.05%-18.33%-39.62% 278M
+4.39%+13.23%+193.39%+305.93% 19.79B
-1.47%+4.31%-40.20%-26.26% 9.59B
+0.72%+5.72%+34.74%+29.88% 7.15B
-1.07%+0.16%-31.00% - 5.23B
-0.45%+0.93%-24.29%-27.76% 4.9B
+2.85%+5.74%+213.30%-35.82% 4.67B
+1.43%+5.81%-23.77%-25.24% 4.13B
-7.42%-9.54%+84.72%+90.38% 4.09B
-2.97%-5.81%-23.11%-44.95% 2.41B
Average -0.67%+1.34%+36.55%+25.17% 6.22B
Weighted average by Cap. +0.82%+5.33%+73.79%+102.79%

Financials

2024 2025
Net sales 437M 64.21M 56.3M 51.89M 48.58M 91.1M 6.06B 92.99M 624M 241M 2.99B 241M 236M 10.38B 364M 53.48M 46.9M 43.23M 40.47M 75.89M 5.05B 77.46M 520M 201M 2.49B 201M 196M 8.65B
Net income 34.53M 5.08M 4.45M 4.1M 3.84M 7.2M 479M 7.35M 49.32M 19.08M 237M 19.06M 18.65M 821M 3.59M 527K 462K 426K 399K 748K 49.75M 764K 5.12M 1.98M 24.59M 1.98M 1.94M 85.27M
Net Debt -434M -63.84M -55.97M -51.59M -48.3M -90.57M -6.02B -92.45M -620M -240M -2.98B -240M -234M -10.32B -210M -30.92M -27.11M -24.99M -23.4M -43.87M -2.92B -44.78M -300M -116M -1.44B -116M -114M -5B
Logo Tellgen Corporation
Tellgen Corp is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The Company's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The Company conducts its business in the domestic and overseas markets.
Employees
683
Date Price Change Volume
26/06/26 CN¥11.81 -2.64% 2,768,500
25/06/26 CN¥12.13 -2.26% 3,417,640
24/06/26 CN¥12.41 -3.05% 3,583,410
23/06/26 CN¥12.80 +2.07% 3,724,021

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300642 Stock